The FDA Could Soon Review the Pfizer Vaccine for Children Ages 5 to 11

Indonesia Berita Berita

The FDA Could Soon Review the Pfizer Vaccine for Children Ages 5 to 11
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 voguemagazine
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 51%

If all goes as planned, millions of children could be vaccinated by Halloween

that trial results for children under 5 are not expected until fall of this year at the absolute earliest, meaning that parents of babies, toddlers, and preschool-age children will have to live with the uncertainty of not knowing whether their families are

protected for a while longer. Still, this constitutes a major win in the U.S.’s pandemic fight, as there are more than 20 million children in this country who are between the ages of 5 and 11. Hopefully, the FDA will act swiftly to protect them from the virus.Sign Up Now

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

voguemagazine /  🏆 715. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pfizer says COVID-19 vaccine works in kids ages 5 to 11, will seek authorizationPfizer says COVID-19 vaccine works in kids ages 5 to 11, will seek authorizationPfizer said its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
Baca lebih lajut »

Pfizer says its COVID-19 vaccine is safe and effective for children ages 5 to 11Pfizer says its COVID-19 vaccine is safe and effective for children ages 5 to 11Pfizer and its German partner, BioNTech, said they would submit their data to the FDA for emergency use authorization.
Baca lebih lajut »

Pfizer says its Covid vaccine is safe and effective for children ages 5 to 11Pfizer says its Covid vaccine is safe and effective for children ages 5 to 11BREAKING: Pfizer-BioNTech says its Covid-19 vaccine is safe and effective for children ages 5 to 11, and that the companies will submit their data to the FDA for emergency use authorization.
Baca lebih lajut »

Covid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer saysCovid-19 vaccine for 5- to 11-year-olds is safe and shows 'robust' antibody response, Pfizer saysA Phase 2/3 trial of Pfizer/BioNTech's two-dose Covid-19 vaccine for children ages 5 to 11 showed it is safe and generated a 'robust' antibody response.
Baca lebih lajut »

Pfizer says its Covid vaccine is safe and effective for childrenPfizer says its Covid vaccine is safe and effective for childrenPfizer-BioNTech says its Covid-19 vaccine is safe and effective for children ages 5 to 11, and that the companies will submit their data to the FDA for emergency use authorization.
Baca lebih lajut »



Render Time: 2025-04-21 18:16:06